Behavidence develops machine learning-based tools to detect and assist with remote monitoring and management of mental health conditions such as depression, anxiety and ADHD via passive digital biomarkers. Its products are positioned for measurement-based outcomes including monitoring employee burnout and stress, predicting relapse, screening, and remote monitoring for clinical interventions and comorbid conditions. The company says its digital solutions have been adopted by health organizations, tech, commercial and government entities. Behavidence has secured more than $1 million in contracts with customers across the United States, Europe, Africa and Asia. Named clients include the Department of Veterans Affairs, Discovery Health Insurance and Essen Health Care. The company plans to use new funding to further develop its machine learning tools.

Total raised

$4M

Funding rounds

1

Latest round

Seed

Latest activity

Mar 2022